findmyKOL
Clinical trialNCT00441467CompletedPhase 2Interventional

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

SponsorEleison Pharmaceuticals LLC.Enrollment22Soft Tissue Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Premiere Oncology of Arizona

    Scottsdale, Arizona, United States

  • Arizona Cancer Center

    Tucson, Arizona, United States

  • Stanford Cancer Center

    Stanford, California, United States

  • H. Lee Moffitt Cancer Center

    Tampa, Florida, United States

  • Washington University School of Medicine, Division of Oncology

    St Louis, Missouri, United States

  • University of New Mexico Cancer Research and Treatment Center

    Albuquerque, New Mexico, United States

  • St. Vincent'S Comprehensive Cancer Center

    New York, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2007
Primary completion
31 Oct 2008
Completion
31 Oct 2008
Last update posted
25 Mar 2015
Registered enrollment
22
Registry id
NCT00441467

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.